Target intelligence / Profile preview

RNA, U4 small nuclear 54, pseudogene (RNU4-54P)

Target
RNU4-54P
Molecular classification
Other (pseudogene, non-coding RNA family)
01

Overview

RNU4-54P is classified as a pseudogene annotated for RNA, U4 small nuclear 54. Pseudogenes do not produce functional proteins or functional RNA and lack known biological functions, molecular interactions, or disease associations. There is no evidence that RNU4-54P serves as a receptor, drug target, biomarker, or has clinical relevance. Most small nuclear RNA pseudogenes are non-functional genetic elements that arise by duplication or retrotransposition and are not therapeutically actionable. The U4 small nuclear RNA family is crucial for spliceosome function in its canonical genes (e.g., RNU4-2, not RNU4-54P). There is no evidence from sequencing or clinical databases for biological or disease relevance of RNU4-54P; major studies focus on RNU4-2 and other functional snRNA genes. The vast majority of snRNA pseudogenes, including RNU4-54P, are considered non-functional without any protein or RNA product. Published literature and gene databases (GeneCards, NCBI) do not describe therapeutic drug interactions, target roles, biomarker status, or links to pathology for RNU4-54P.

Other names
RNU4-54P

Beyond the preview

Go deeper on RNA, U4 small nuclear 54, pseudogene (RNU4-54P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 54, pseudogene (RNU4-54P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call